Health News Archive - February 01, 2010
NEW YORK, Feb. 1 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. ("NeoStem" or the "Company") (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S.
CHANGCHUN, China and LOS ANGELES, Feb. 1 /PRNewswire-Asia/ -- China Yongxin Pharmaceutical, Inc. (OTC Bulletin Board: CYXN) (the Company), one of the fastest growing, vertically-integrated health products companies in China, today announced it has retained Strategic Growth International, Inc.
HARBIN, China, Feb. 1 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc.
DEFUNIAK SPRINGS, Fla., Feb. 1 /PRNewswire/ -- The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder. That's why Professional Products, Inc.
MORRISTOWN, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and HRA Pharma today announced an exclusive licensing agreement for Watson to become the commercial partner for ulipristal acetate (UPA), a selective progesterone receptor modulator in the U.S.
WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the 12th Annual BIO CEO and Investor Conference on Monday, February 8th, 2010 at 2:00 p.m.
WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc.
NATICK, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the settlement of three patent disputes with Johnson & Johnson (J&J).
PARSIPPANY, N.J., Feb.
BERKELEY HEIGHTS, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Authentidate Holding Corp.